MedPath

Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses

Not Applicable
Completed
Conditions
Hyperopia
Myopia
Astigmatism
Interventions
Device: fanfilcon A
Device: enfilcon A
Registration Number
NCT02423109
Lead Sponsor
Coopervision, Inc.
Brief Summary

Bilateral dispensing clinical trial of fanfilcon A toric lens verses enfilcon A toric lens over two weeks.

Detailed Description

Evaluation of the clinical performance of an investigational silicone-hydrogel lens called fanfilcon A (test) compared to a FDA-cleared commercially available contact lens called enfilcon A toric lens (control) when worn on a daily wear basis over 2 weeks in a randomized, bilateral, cross-over, dispensing study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Are at least 17 years of age for Canada and 18 years of age for the USA and have full legal capacity to volunteer;

  • Have read and signed an information consent letter;

  • Are willing and able to follow instructions and maintain the appointment schedule;

  • Are an adapted soft contact lens wearer;

  • Require spectacle lens powers in both eyes;

    • Sphere: between -0.50 to -6.00 diopters and
    • Astigmatism: between -1.25 to -2.00 and
    • Axis: 180 ± 20 degrees
  • Are willing to wear contact lens in both eyes;

  • Have manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye;

  • To be eligible for lens dispensing, the subject must have VA of logMAR equivalent of 20/30 or better in each eye with the study lenses and the investigator must judge the fit including toric orientation as acceptable;

Exclusion Criteria
  • Are participating in any concurrent clinical or research study;
  • Have any known active* ocular disease and/or infection;
  • Have a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  • Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  • Have known sensitivity to the diagnostic pharmaceuticals to be used in the study;
  • Are pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit);
  • Are aphakic;
  • Have undergone refractive error surgery;

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
fanfilcon Afanfilcon AEach subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.
enfilcon Afanfilcon AEach subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.
enfilcon Aenfilcon AEach subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.
fanfilcon Aenfilcon AEach subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.
Primary Outcome Measures
NameTimeMethod
Comfort PreferenceDispensing (Baseline) and 2 weeks

Subjective assessment for comfort preference for each lens pair. Choices: fanfilcon A lens, enfilcon A lens, No preference.

Comfort (Subjective Rating Scale)Dispensing (Baseline) and 2 weeks

Participant rating for comfort at dispense visit and at the 2 week follow-up on a subjective rating scale (0-100, 0=cannot be worn. Causes pain,100=Cannot be felt ever)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Clinical Research Center, University of California, Berkeley

🇺🇸

Berkeley, California, United States

Center for Contact Lens Research, University of Waterloo

🇨🇦

Waterloo, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath